Blaine Cloud, Ph.D., to Lead Consumer-Side Research and Consulting as Senior Director at Evolution Marketing Research
Blue Bell, PA (PRWEB) August 18, 2011
Evolution Marketing Research, a leading supplier of insights and intelligence to the healthcare industry, announced today that Blaine Cloud, Ph.D., has joined the company as Senior Director. As a skilled researcher with experience delivering robust consumer insights, both as a client and a consultant, Cloud will strengthen Evolutions already deep knowledge of medical markets and customer/patient behavior.
In this latter area, Clouds impact will be especially significant. Evolution leads the industry in physician-side marketing research, said Evolution Principal Jim Cummings. We understand the physiology behind our clients products, and we talk to physicians well. While weve delivered solid results on the consumer side of the business, weve been less visible than wed like. Dr. Clouds experience providing intelligence to power direct-to-consumer (DTC) campaigns and product-line extensions for major pharmaceutical brands will increase our capabilities and help us deliver richer insights to our customers.
Cloud earned his doctorate in cognitive neuropsychology and researched how the brain processes and remembers rational and emotional information at leading research hospitals during the early 1990s. He first applied this training to the pharmaceutical industry as a consultant at V2, Inc., where he worked to understand drivers of physician and patient behavior. His work at V2 focused primarily on qualitative marketing research for top domestic and international pharmaceutical clients looking to position their brands favorably in the marketplace or pursue new product development explorations.
At GlaxoSmithKline, Cloud leveraged this consulting experience in positions of increasing responsibility in Marketing Research, Brand Management and Global Strategic Marketing. As an internal market researcher, he supported Paxil and Coreg, providing the creative insights and intelligence to underpin four DTC campaigns, three indication/line extension launches and several professional positioning projects. In these efforts, Cloud worked extensively with advertising agencies and across brand teams, synthesizing information and gaining consensus among various project stakeholders. In Global Strategic Marketing, he worked in the R&D organization to guide clinical development and positioning of early assets.
Cloud joined Evolution officially on June 1. In his new role, Cloud will draw on his depth of experience and will be tasked with consulting and product development. In fact, Cloud is actively refining two patient-focused methodologies that will be available in the near future. The first methodology will enable brand teams to be guided by patients needs when looking to develop new DTC campaigns, clinical trials or new products and indications, leading to stronger patient positioning platforms and targeted creative execution. The second methodology will help a brand team more effectively and confidently improve an existing product or campaign by understanding why patients choose the brand in question over a competitors brand.
Evolutions impressive suite of creative methodologies was one of the key factors that attracted Cloud to the company. The methodologies Evolution offers and the high level of client satisfaction was a driving force behind my decision to join the team, he said. I was also impressed by the people, who exhibit an extraordinarily high level of intelligence and creativity. I look forward to contributing to Evolutions success.
For more information about Clouds availability to consult on a specific project or Evolution’s research offerings, please call 866-486-0873 or visit http://www.evolved-mr.com.
About Evolution Marketing Research
Evolution Marketing Research is a healthcare marketing research firm that provides qualitative and quantitative research, consulting services, project management, advisory board monitoring and other marketing research services to pharmaceutical, biotech and medical device companies all over the world. Company principals John Taenzler, Ph.D., Jim Cummings and James Heasley, Ph.D., who are backed by a seasoned team of analysts and researchers, bring their collective experience to bear on projects at all phases of the product lifecycle, from opportunity and licensing assessments, to product crafting in support of phase III clinical trial design, to development of the commercial platform for developmental and in-line products. To learn more call 866-486-0873 or visit http://www.evolved-mr.com.
# # #
Related Neuropsychology Press Releases